| 26 |
Dong-A ST highlights oncology, immunology pipelines at BIO USA 2026
|
2026-09-03 |
415 |
| 25 |
Dong-A ST to Build AI Drug Discovery Platform, Targets First Version This Year
|
2026-09-03 |
357 |
| 24 |
[AACR] Dong-A ST and Aptis present 9 anticancer candidates, including ADCs
|
2026-05-18 |
1106 |
| 23 |
Dong-A ST secures Canadian approval for Stelara biosimilar ‘Imuldosa’
|
2026-05-18 |
900 |
| 22 |
Dong-A ST, Accord launch Stelara biosimilar Imuldosa in US
|
2025-11-14 |
1728 |
| 21 |
Dong-A ST, SK bioscience, and Onconic Therapeutics are among 7 Innovative Pharmaceutical Companies
|
2025-01-08 |
2240 |
| 20 |
Dong-A ST Secures European Approval for Stelara Biosimilar IMULDOSA
|
2025-01-08 |
2207 |
| 19 |
CHMP Recommends the Approval of Dong-A ST’s IMULDOSA, a Biosimilar to STELARA®
|
2024-10-23 |
2412 |
| 18 |
US FDA Approves Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®
|
2024-10-23 |
2292 |
| 17 |
Dong-A ST's ECG Monitoring Platform Hicardi+ H100 Receives U.S. FDA Approval
|
2024-09-30 |
1816 |
